• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHOU Dunhui, YUE Long, WANG Zhixiang, DANG Beilei, YAN Tingxuan, HUANG Dechun. Preparation of cefuroxime axetil particles by supercritical CO2 anti-solvent technology[J]. Journal of China Pharmaceutical University, 2013, 44(6): 596-599. DOI: 10.11665/j.issn.1000-5048.20130621
Citation: ZHOU Dunhui, YUE Long, WANG Zhixiang, DANG Beilei, YAN Tingxuan, HUANG Dechun. Preparation of cefuroxime axetil particles by supercritical CO2 anti-solvent technology[J]. Journal of China Pharmaceutical University, 2013, 44(6): 596-599. DOI: 10.11665/j.issn.1000-5048.20130621

Preparation of cefuroxime axetil particles by supercritical CO2 anti-solvent technology

More Information
  • Cefuroxime axetil micro particles were prepared by using supercritical CO2 anti-solvent technology. With volume average particle size as the main evaluation, on the basis of single factor experiments orthogonal experimental design was used to optimize the preparation process of cefuroxime axetil particles. The experiments such as particle size distribution, scanning electro microscope analysis(SEMA), infrared spectrum(IR)and differential scanning calorimetry(DSC)were used to analyze the particles. The orthogonal experimental optimization process conditions were set as follows: crystallization pressure 10 MPa, crystallization temperature 50 ℃ and mass concentration of cefuroxime axetil 6 mg/mL, Under the optimum conditions, the volume average particle size was 6. 729 μm, IR and DSC analysis showed that the chemical structure didn′t change but the thermodynamic properties of cefuroxime axetil might transfer transform to amorphous.
  • [1]
    Cai JY,Huang DC,Wang ZX,et al.The application of supercritical anti-solvent technology in the field of microparticulate powder[J].Pharmacy Today(今日药学),2011,21(12):768-772.
    [2]
    Liu Q,Zhu MH,Zu YG,et al.Comparative antioxidant activity of nanoscale lignin prepared by a supercritical antisolvent(SAS)process with non-nanoscale lignin[J].Food Chem,2012,135(1):63-67.
    [3]
    Jin HY,Melinda H,Ram B G, et al.Preparation of thalidomide nano-flakes by supercritical antisolvent with enhanced mass transfer[J].Particuol,2012,10(1):17-23.
    [4]
    Huang J,Yan TX,Wang ZX,et al.Research on preparation of baicalein particles by supercritical CO2 anti-solvent technology[J].Chin Tradit Herbal Drugs(中草药),2013,44(8):970-973.
    [5]
    Montes A,Tenorio A,Gordillo MD, et al.Screening design of experiment applied to supercritical antisolvent precipitation of amoxicillin: exploring new miscible conditions[J].J Supercritical Fluids,2010, 51(3):399-403.
    [6]
    Zordi ND,Kikic I,Moneghini M,et al.Piroxicam solid state studies after processing with SAS technique[J].J Supercritical Fluids,2010, 55(1):340-347.
    [7]
    Zhang JL,Bai P.Research on synthesis of cefuroxime axetil[J].Hebei J Ind Sci Technol(河北工业科技),2006,23(6):328-329.
    [8]
    Wang JX, Zhang QX, Zhou Y, et al. Microfluidic synthesis of amorphous cefuroxime axetil nanoparticles with size-dependent and enhanced dissolution rate[J].Chem Engineering J,2010,162(2):844-851.
    [9]
    Zhang JY,Shen ZG,Zhong J, et al.Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants[J].Int J Pharm,2006,323(1/2):153-160.
    [10]
    Varshosaz J,Hassanzadeh F,Mahmoudzadeh M,et al.Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercri-tical fluid technology[J].Powder Technol,2009,189(1):97-102.
  • Related Articles

    [1]YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403
    [2]SI Lianghui, MA Hui, ZHOU Jinpei, ZHANG Huibin. Advances in antidiabetic small molecule ABHD6 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 125-134. DOI: 10.11665/j.issn.1000-5048.20170201
    [3]WU Shiwei, ZHANG Hui, LI Qianbin, HU Gaoyun. Advances in thioredoxin reductase and its inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 511-520. DOI: 10.11665/j.issn.1000-5048.20160502
    [4]XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501
    [5]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [6]LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302
    [7]LI Tonghui, GUO Hao, LU Tao, WANG Yue, LU Shuai, TANG Weifang. Advances in the research of FLT3 inhibitors for acute myeloid leukemia[J]. Journal of China Pharmaceutical University, 2015, 46(2): 153-161. DOI: 10.11665/j.issn.1000-5048.20150203
    [8]LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101
    [9]Advances in the research of factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2010, 41(2): 104-111.
    [10]Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6.

Catalog

    Article views (1254) PDF downloads (1999) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return